ATRAcTR (Authentic Transparent Relevant Accurate Track-Record): A Screening Tool to Assess the Potential for Real-World Data Sources to Support Creation of Credible Real-World Evidence for Regulatory Decision-Making

Author:

Berger Marc1,Li James2,Crown William3,Zou Kelly2

Affiliation:

1. Marc L. Berger, LLC

2. Viatris (United States)

3. Brandeis University

Abstract

Abstract Background: Adoption and use of RWD for decision-making has been complicated by concerns regarding whether RWD was fit-for-purpose or was of sufficient validity to support the creation of credible RWE. This has greater urgency as regulatory agencies begin to use real world evidence (RWE) to inform decisions about treatment effectiveness. Methods: We developed a practical screening tool to assess the quality of RWD sources using the framework of Modern Validity Theory. While there has been some convergence of conceptual frameworks, consensus has yet to emerge regarding how to specifically evaluate whether RWD is reliable and fit-for-purpose. We developed a screening tool consistent with the current frameworks and how researchers generally evaluate existing RWD sources for research that they intend to submit to regulatory agencies. Results: The tool has five dimensions: authenticity, transparency, relevance, accuracy, and reliability. Based upon these dimensions, we developed what more detailed information should be sought by researchers to screen potential RWD sources. Conclusions: Using a hypothetical example of a medical claims data source, we showed that responding to the tool would not require an extraordinary burden or a lengthy document. This RWD screening tool, which is ready for immediate use, is consistent with current conceptual frameworks to assess whether RWD is fit-for-purpose and adds the additional consideration of experience with RWD sources consistent with Modern Validity Theory.

Publisher

Research Square Platform LLC

Reference45 articles.

1. Arlett, P., DARWIN EU (Data Analytics and Real World Interrogation Network):, Available online: (2020). https://www.ema.europa.eu/en/documents/presentation/presentation-proposal-darwin-eu-data-analytics-real-world-interrogation-network-parlett-ema_en.pdf (Accessed on May 31, 2023)

2. Real-world evidence in EU Medicines regulation: Enabling Use and Establishing Value;Arlett P;Clin. Pharmacol. Ther.,2021

3. Contributions of Real-World Evidence in European Agency’s Regulatory Decision Making;Bakker E;Clin. Pharmacol. Ther.,2022

4. Optimizing the Leveraging of Real World Data: How It Can Improve the Development and Use of Medicines;Berger ML;Value in Health,2015

5. How can we make more rapid progress in the leveraging of real-world evidence by regulatory decision makers?;Berger ML;Value in Health,2022

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3